Physical therapy, a third wheel in the management of Parkinson’s disease
Objective: To reinforce the importance of physical therapy in the management of Parkinson's disease. Background: Unsteadiness, falling, and tendency to fall are frequent symptoms of…Parkinsonism due to hypermanganism in the background of cirrhosis and recovery by CaNaEDTA
Objective: To present a patient diagnosed with secondary hypermanganism due to cirrhosis whose extrapyramidal findings had recovered significantly after chelation therapy. Background: Manganese is an…Creativity related to dopaminergic treatment. A multicenter study
Objective: To study patients with Parkinson´s disease (PD) and enhanced creativity related to dopaminergic therapy. Background: Impulse control disorders (ICD) including pathological gambling, hypersexuality, and…The effect of Mozart piano sonata on Parkinsonian tremor, rigidity and bradykinesia
Objective: In this study we intend to assess the effect of Mozart piano sonata on Parkinsonian tremor. Background: The effect of rhythmic auditory stimulation and…Nilotinib significantly alters CSF biomarkers and increases endogenous dopamine in open-label phase I clinical trial in Parkinson’s disease with dementia and Lewy body dementia
Objective: The objective was to determine whether Nilotinib crosses the blood brain barrier (BBB). Background: Parkinson's disease (PD) involves death of dopamine producing neurons in…Apomorphine treatment in advanced Parkinson’s disease (PD): Duration of treatment and safety experience in a managed care program in Germany
Objective: To evaluate the duration of treatment (DOT) and safety of apomorphine continuous subcutaneous infusion (CSI) in patients with advanced PD inscribed in a managed…Establishment of InMotion, an independent, fee-free community center for persons with movement disorders
Objective: To describe the establishment of a community center, InMotion (IM), for persons with movement disorders. Background: Needs of people with movement disorders grow with…When is the worst period of nocturnal hypokinesia in Parkinson’s disease? A sensor-based analysis
Objective: To quantify the number of turning in bed throughout the night as a determinant of the severity of nocturnal hypokinesia. Background: Nocturnal hypokinesia or…Regional differences in the results of a phase 2b study of tozadenant in Parkinson’s disease patients with motor fluctuations
Objective: To assess how the efficacy of tozadenant differed by region in a randomized, double-blind, placebo-controlled trial of Parkinson's disease patients with motor fluctuations. Background:…Distribution of oscillatory activities in MRI confirmed subthalamic nucleus subregions
Objective: To explore the differences and similarities of oscillatory activity between subregions of the subthalamic nucleus (STN). Background: In Parkinson's disease (PD), treatment driven changes…
- « Previous Page
- 1
- …
- 383
- 384
- 385
- 386
- 387
- …
- 405
- Next Page »